Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
Background: There is a lack of biomarkers for predicting the efficacy of immunotherapy in triple-negative breast cancer (TNBC). Hence, we constructed an immune risk score (IRS) model to predict the prognosis of patients with TNBC and evaluate those who are sensitive to immunotherapy.Methods: The rib...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2022-11-01
|
| Seri Bilgileri: | Frontiers in Genetics |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1067254/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
